Augmentin 875 mg/125 mg tablets

Augmentin is a widely prescribed broad-spectrum antibiotic containing a combination of amoxicillin and clavulanic acid. It was originally developed by Beecham Pharmaceuticals in the United Kingdom during the 1970s. Following several corporate mergers, the brand is now owned by GlaxoSmithKline (GSK), a major global healthcare company headquartered in London.

Due to its global demand, Augmentin is manufactured in various high-standard facilities worldwide. For the European market, including Italy, significant production often occurs at the Glaxo Wellcome Production site in Mayenne, France. However, it is also manufactured in other locations such as India and the United Kingdom. In the United States, rights and specific manufacturing facilities for certain versions were previously divested to other entities like Dr. Reddy's Laboratories, but GSK maintains the core brand rights globally.